Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 16 | 2022 | 85 | 3.200 |
Why?
|
| p21-Activated Kinases | 4 | 2023 | 6 | 2.170 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 97 | 2.150 |
Why?
|
| Calcium | 12 | 2022 | 354 | 1.450 |
Why?
|
| Embryonic Stem Cells | 6 | 2014 | 10 | 1.310 |
Why?
|
| Mice | 17 | 2023 | 1249 | 1.090 |
Why?
|
| Animals | 22 | 2023 | 3293 | 1.030 |
Why?
|
| Reactive Oxygen Species | 4 | 2023 | 104 | 1.010 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2013 | 27 | 0.770 |
Why?
|
| Calcium Signaling | 4 | 2022 | 110 | 0.750 |
Why?
|
| Heart Ventricles | 4 | 2018 | 82 | 0.720 |
Why?
|
| Oxygen | 1 | 2021 | 56 | 0.700 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 4 | 2021 | 20 | 0.610 |
Why?
|
| Connexin 43 | 3 | 2012 | 5 | 0.530 |
Why?
|
| Signal Transduction | 4 | 2014 | 397 | 0.530 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2013 | 7 | 0.510 |
Why?
|
| Cardiomegaly | 2 | 2013 | 4 | 0.510 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 3 | 2021 | 17 | 0.500 |
Why?
|
| Sinoatrial Node | 2 | 2023 | 3 | 0.470 |
Why?
|
| Action Potentials | 4 | 2022 | 79 | 0.460 |
Why?
|
| Heart Rate | 2 | 2023 | 104 | 0.450 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2014 | 6 | 0.420 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 44 | 0.410 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 18 | 0.400 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 3 | 0.400 |
Why?
|
| Excitation Contraction Coupling | 1 | 2013 | 9 | 0.400 |
Why?
|
| Antioxidants | 1 | 2013 | 56 | 0.390 |
Why?
|
| Paracrine Communication | 1 | 2012 | 4 | 0.390 |
Why?
|
| Heart Conduction System | 1 | 2012 | 6 | 0.390 |
Why?
|
| Heart Failure | 4 | 2022 | 141 | 0.380 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 29 | 0.380 |
Why?
|
| Up-Regulation | 1 | 2012 | 141 | 0.370 |
Why?
|
| Gap Junctions | 2 | 2008 | 11 | 0.360 |
Why?
|
| Biological Clocks | 2 | 2008 | 11 | 0.360 |
Why?
|
| Cell Differentiation | 3 | 2010 | 125 | 0.340 |
Why?
|
| Cells, Cultured | 5 | 2018 | 465 | 0.310 |
Why?
|
| Rabbits | 3 | 2022 | 165 | 0.310 |
Why?
|
| Pacemaker, Artificial | 1 | 2008 | 11 | 0.290 |
Why?
|
| Tissue Engineering | 1 | 2008 | 24 | 0.290 |
Why?
|
| Fibroblasts | 1 | 2007 | 50 | 0.270 |
Why?
|
| Cell Cycle | 1 | 2006 | 33 | 0.250 |
Why?
|
| Myocardium | 3 | 2013 | 100 | 0.240 |
Why?
|
| Heart Atria | 2 | 2022 | 22 | 0.210 |
Why?
|
| Sick Sinus Syndrome | 1 | 2023 | 1 | 0.200 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2023 | 9 | 0.200 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2022 | 3 | 0.190 |
Why?
|
| Inositol | 1 | 2021 | 5 | 0.180 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 49 | 0.180 |
Why?
|
| Enzyme Inhibitors | 2 | 2012 | 113 | 0.160 |
Why?
|
| NFATC Transcription Factors | 2 | 2010 | 9 | 0.160 |
Why?
|
| Cell Line | 2 | 2012 | 250 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2014 | 70 | 0.140 |
Why?
|
| Electrophysiological Phenomena | 1 | 2018 | 8 | 0.140 |
Why?
|
| Cell Communication | 2 | 2008 | 21 | 0.140 |
Why?
|
| Myocardial Contraction | 2 | 2008 | 36 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 523 | 0.130 |
Why?
|
| Rats | 4 | 2022 | 627 | 0.130 |
Why?
|
| Boron Compounds | 2 | 2007 | 2 | 0.130 |
Why?
|
| Estrenes | 2 | 2007 | 2 | 0.130 |
Why?
|
| Pyrrolidinones | 2 | 2007 | 4 | 0.130 |
Why?
|
| Type C Phospholipases | 2 | 2007 | 8 | 0.130 |
Why?
|
| Electrophysiology | 2 | 2008 | 95 | 0.120 |
Why?
|
| Protein Kinase C | 2 | 2013 | 47 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2012 | 131 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 232 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 23 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2013 | 39 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2013 | 53 | 0.100 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2013 | 1 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 2014 | 26 | 0.100 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 7 | 0.100 |
Why?
|
| Protein Isoforms | 3 | 2010 | 36 | 0.100 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 4 | 0.100 |
Why?
|
| Cell Size | 1 | 2013 | 6 | 0.100 |
Why?
|
| Isotonic Solutions | 1 | 2013 | 8 | 0.100 |
Why?
|
| Organophosphorus Compounds | 1 | 2013 | 5 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2014 | 87 | 0.100 |
Why?
|
| Piperidines | 1 | 2013 | 13 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 62 | 0.100 |
Why?
|
| Cell Survival | 1 | 2013 | 98 | 0.100 |
Why?
|
| Gene Expression | 1 | 2014 | 176 | 0.100 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Chalcones | 1 | 2012 | 2 | 0.100 |
Why?
|
| Lithium Chloride | 1 | 2012 | 3 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 8 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2012 | 10 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 16 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2013 | 81 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 173 | 0.090 |
Why?
|
| Heart | 2 | 2010 | 59 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2013 | 281 | 0.090 |
Why?
|
| beta Catenin | 1 | 2012 | 57 | 0.090 |
Why?
|
| Phenylephrine | 2 | 2013 | 4 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 370 | 0.090 |
Why?
|
| Male | 3 | 2023 | 12439 | 0.090 |
Why?
|
| Nifedipine | 2 | 2010 | 6 | 0.090 |
Why?
|
| Female | 3 | 2023 | 12936 | 0.080 |
Why?
|
| Calcium Channels, L-Type | 2 | 2010 | 50 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 315 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 31 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 45 | 0.080 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 5 | 0.070 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2008 | 1 | 0.070 |
Why?
|
| Kinetics | 1 | 2008 | 176 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2007 | 17 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2007 | 13 | 0.070 |
Why?
|
| Xanthenes | 1 | 2007 | 4 | 0.070 |
Why?
|
| Endothelin-1 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2007 | 16 | 0.070 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2007 | 9 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2007 | 29 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 34 | 0.070 |
Why?
|
| Time Factors | 2 | 2008 | 1263 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2007 | 30 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 80 | 0.060 |
Why?
|
| Thapsigargin | 1 | 2006 | 4 | 0.060 |
Why?
|
| Egtazic Acid | 1 | 2006 | 11 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 239 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 1 | 2006 | 8 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2006 | 13 | 0.060 |
Why?
|
| Chlorofluorocarbons, Methane | 1 | 2006 | 1 | 0.060 |
Why?
|
| Epinephrine | 1 | 2006 | 29 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2006 | 57 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2007 | 134 | 0.060 |
Why?
|
| Humans | 3 | 2021 | 22914 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2003 | 18 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 24 | 0.050 |
Why?
|
| Sodium | 1 | 2003 | 56 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 1 | 0.050 |
Why?
|
| Prealbumin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Calcium, Dietary | 1 | 2022 | 11 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2022 | 41 | 0.050 |
Why?
|
| Angiotensin II | 2 | 2013 | 3 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 19 | 0.040 |
Why?
|
| Cytoplasm | 2 | 2010 | 32 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2008 | 41 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 3 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 11 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 60 | 0.030 |
Why?
|
| Aorta | 1 | 2013 | 16 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 79 | 0.030 |
Why?
|
| Apoptosis | 1 | 2013 | 194 | 0.020 |
Why?
|
| Cats | 1 | 2010 | 28 | 0.020 |
Why?
|
| Muscle Development | 1 | 2010 | 3 | 0.020 |
Why?
|
| Troponin T | 1 | 2010 | 3 | 0.020 |
Why?
|
| Cadmium | 1 | 2010 | 11 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 14 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 25 | 0.020 |
Why?
|
| Stem Cells | 1 | 2010 | 34 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 102 | 0.020 |
Why?
|
| Cattle | 1 | 2009 | 110 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2009 | 33 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 260 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2009 | 58 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Androstadienes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2008 | 13 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2008 | 28 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 54 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 57 | 0.020 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2007 | 1 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 314 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 117 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 153 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2007 | 69 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 302 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2007 | 276 | 0.020 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2006 | 1 | 0.020 |
Why?
|
| Bromochlorofluorocarbons | 1 | 2006 | 1 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 38 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 314 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 68 | 0.020 |
Why?
|